Arix Bioscience plc - Arix to Host Oncology KOL Event on October 30, 2018

LONDON, October 25, 2018 /PRNewswire/ --

• Webcast to begin at 12:00pm ET
• Focus on recent developments in synthetic lethality and bi-specific antibodies within oncology

Arix Bioscience plc (LSE: ARIX) ("Arix"), a global healthcare and life science company supporting medical innovation today announced that the Company will host a live webcast in conjunction with its Oncology KOL Day on Tuesday, October 30, 2018 at 12:00pm ET in New York, NY.

A webcast of the presentation will be accessible live at 12:00pm ET and available to replay on Arix's website at https://arixbioscience.com/presentations.

For more information on the Event, please contact [email protected].

Enquiries   
For more information on Arix, please contact:
Arix Bioscience plc 
Charlotte Parry, Head of Investor Relations
+44(0)20-7290-1072
[email protected]  

Optimum Strategic Communications 
Mary Clark, Supriya Mathur
+44(0)203-714-1787
[email protected]

Burns McClellan (US Media & IR Enquiries) 
Bill Slattery Jr., Nancie Steinberg
+1-212-213-0006
[email protected]

About Arix Bioscience plc 
Arix Bioscience plc is a global healthcare and life science company supporting medical innovation. Headquartered in London and with an office in New York, Arix Bioscience sources, finances and builds world class healthcare and life science businesses addressing medical innovation at all stages of development. Operations are supported by privileged access to breakthrough academic science and strategic relationships with leading research accelerators and global pharmaceutical companies.

Arix Bioscience plc is listed on the Main Market of the London Stock Exchange. For further information, please visit http://www.arixbioscience.com

SOURCE Arix Bioscience plc